• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

止泻药的阿片样活性与止泻活性之间的解离。

Dissociation between opiate-like and antidiarrheal activities of antidiarrheal drugs.

作者信息

Niemegeers C J, McGuire J L, Heykants J J, Janssen P A

出版信息

J Pharmacol Exp Ther. 1979 Sep;210(3):327-33.

PMID:480185
Abstract

Three synthetic antidiarrheals, diphenoxylate, loperamide and SC 27166, and two narcotics, morphine and codeine, were evaluated in rats by the intravenous and oral route for specificity and duration of their antidiarrheal, opiate-like and acute toxic effects. The activity in the castor oil test, the tail withdrawal test and the acute toxicity test was used to determine the relative antidiarrheal specificity and relative safety margins. An analysis of animal and clinical data indicate these tests to be excellent indicators of clinical usefulness and specificity. Intravenously, all five agents induced opiate-like central effects, loperamide and SC 27166 at near toxic doses only. When administered orally loperamide and SC 27166 were devoid of opiate-like central nervous system activity. Analysis of the plasma levels after oral loperamide indicated that this drug does not attain a concentration high enough to induce opiate-like central effects. All agents were effective antidiarrheals by the oral route with loperamide being the most potent (ED50 = 0.15 mg/kg), longest acting (ED50 8 hr = 1.81 mg/kg) and most specific (relative antidiarrheal specificity, 8 hr greater than or equal to 88) and having the greatest relative safety margin (8 hr = 102).

摘要

通过静脉注射和口服途径,在大鼠身上对三种合成止泻药(地芬诺酯、洛哌丁胺和SC 27166)以及两种麻醉药(吗啡和可待因)的止泻、类阿片样和急性毒性作用的特异性和持续时间进行了评估。蓖麻油试验、甩尾试验和急性毒性试验中的活性用于确定相对止泻特异性和相对安全范围。对动物和临床数据的分析表明,这些试验是临床效用和特异性的优秀指标。静脉注射时,所有五种药物都能产生类阿片样中枢作用,只有洛哌丁胺和SC 27166在接近中毒剂量时才会出现。口服洛哌丁胺和SC 27166时,它们没有类阿片样中枢神经系统活性。口服洛哌丁胺后的血浆水平分析表明,该药物达不到足以产生类阿片样中枢作用的浓度。所有药物通过口服途径都是有效的止泻药,其中洛哌丁胺效力最强(半数有效量=0.15毫克/千克)、作用时间最长(8小时半数有效量=1.81毫克/千克)、特异性最高(相对止泻特异性,8小时大于或等于88)且相对安全范围最大(8小时=102)。

相似文献

1
Dissociation between opiate-like and antidiarrheal activities of antidiarrheal drugs.止泻药的阿片样活性与止泻活性之间的解离。
J Pharmacol Exp Ther. 1979 Sep;210(3):327-33.
2
The pharmacology of SC-27166: a novel antidiarrheal agent.新型止泻药SC-27166的药理学
J Pharmacol Exp Ther. 1977 Dec;203(3):512-26.
3
Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus.新型止泻药SC-27166(2-[3 - 5 - 甲基 - 1, 3, 4 - 恶二唑 - 2 - 基)-3, 3 - 二苯基丙基]-2 - 氮杂双环[2.2.2]辛烷)的止泻及中枢神经系统活性,源于其与脑和肌间神经丛的阿片受体位点结合。
J Pharmacol Exp Ther. 1977 Dec;203(3):527-38.
4
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1: in vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine.洛哌丁胺(R 18 553),一种新型止泻药。第1部分:体内口服药理学及急性毒性。与吗啡、可待因、地芬诺酯和地芬诺辛的比较。
Arzneimittelforschung. 1974 Oct;24(10):1633-6.
5
Is in vivo dissociation between the antipropulsive and antidiarrheal properties of opioids in rats related to gut selectivity?大鼠体内阿片类药物的抗推进和止泻特性之间的解离与肠道选择性有关吗?
Arch Int Pharmacodyn Ther. 1989 Mar-Apr;298:220-9.
6
Investigations on drug produced and subjectively experienced discriminative stimuli. 2. Loperamide, an antidiarrheal devoid of narcotic cue producing actions.对产生和主观体验到的辨别性刺激的药物的研究。2. 洛哌丁胺,一种不产生麻醉提示作用的止泻药。
Life Sci. 1975 Mar 1;16(5):717-27. doi: 10.1016/0024-3205(75)90348-3.
7
Pharmacology of antidiarrheal drugs.止泻药的药理学
Annu Rev Pharmacol Toxicol. 1983;23:279-301. doi: 10.1146/annurev.pa.23.040183.001431.
8
In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide.新型止泻药盐酸利达米定(WHR-1142A)的体内抗蠕动和止泻活性。与地芬诺酯和洛哌丁胺的比较。
Arzneimittelforschung. 1978;28(8a):1448-54.
9
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 2: in vivo parenteral pharmacology and acute toxicity in mice. Comparison with morphine, codeine and diphenoxylate.洛哌丁胺(R 18 553),一种新型止泻药。第2部分:小鼠体内非肠道药理学及急性毒性。与吗啡、可待因及地芬诺酯的比较。
Arzneimittelforschung. 1974 Oct;24(10):1636-41.
10
Opiate agonist action of antidiarrheal agents in vitro and in vivo--findings in support for selective action.止泻药在体外和体内的阿片类激动剂作用——支持选择性作用的研究结果
Naunyn Schmiedebergs Arch Pharmacol. 1978 Jan-Feb;301(3):187-94. doi: 10.1007/BF00507036.

引用本文的文献

1
Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse.非处方阿片类药物滥用的药理学方面。
Molecules. 2020 Aug 27;25(17):3905. doi: 10.3390/molecules25173905.
2
Smoked heroin self-administration in rhesus monkeys.恒河猴的海洛因吸食自我给药行为。
Psychopharmacology (Berl). 1996 Jun;125(3):195-201. doi: 10.1007/BF02247328.
3
Loperamide. Survey of studies on mechanism of its antidiarrheal activity.洛哌丁胺。其抗腹泻活性机制的研究综述。
Dig Dis Sci. 1993 Jun;38(6):977-95. doi: 10.1007/BF01295711.
4
Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency.洛哌丁胺对伴有大便失禁和急迫感的慢性腹泻患者肛门括约肌功能的影响。
Dig Dis Sci. 1982 Sep;27(9):807-14. doi: 10.1007/BF01391374.
5
Local inhibition of myoelectrical activity of human colon by loperamide.洛哌丁胺对人结肠肌电活动的局部抑制作用。
Dig Dis Sci. 1984 Mar;29(3):232-8. doi: 10.1007/BF01296257.
6
Loperamide in acute diarrhoea in childhood: results of a double blind, placebo controlled multicentre clinical trial. Diarrhoeal Diseases Study Group (UK).洛哌丁胺治疗儿童急性腹泻:一项双盲、安慰剂对照的多中心临床试验结果。腹泻病研究组(英国)
Br Med J (Clin Res Ed). 1984 Nov 10;289(6454):1263-7. doi: 10.1136/bmj.289.6454.1263.
7
Pathogenesis and pharmacology of diarrhea.腹泻的发病机制与药理学
Vet Res Commun. 1986 Sep;10(5):355-97. doi: 10.1007/BF02214001.